EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Restoring expression of tumour suppressor PTEN by engineered circular RNA‐enhanced Osimertinib sensitivity in non‐small cell lung cancer

Haoran Li, Zheng Liu, Shaoyi Chen, Jingsheng Cai, Peiyu Wang, Kezhong Chen iD, Mantang Qiu iD

Clinical and Translational Medicine · 2024

DOI: 10.1002/ctm2.1792 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical and Translational Medicine, 2024. Verfasst von Haoran Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Thoracic Oncology Institute/Research Unit of Intelligence Diagnosis and Treatment in Early Non-Small Cell Lung Cancer, Peking University People's Hos…. Hauptthemen laut MEDLINE: PTEN Phosphohydrolase, Carcinoma, Non-Small-Cell Lung, RNA, Circular, Acrylamides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Beijing Nova Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PTEN PhosphohydrolaseCarcinoma, Non-Small-Cell LungRNA, CircularAcrylamidesAniline CompoundsLung NeoplasmsHumansAntineoplastic AgentsCell Line, TumorIndolesPyrimidines

Substanzen

PTEN PhosphohydrolaseRNA, CircularosimertinibPTEN protein, humanAcrylamidesAniline CompoundsAntineoplastic AgentsIndolesPyrimidines

Autor:innen und Institutionen

  • Thoracic Oncology Institute/Research Unit of Intelligence Diagnosis and Treatment in Early Non-Small Cell Lung Cancer, Peking University People's Hospital, Beijing, China.
  • Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China.
  • Institute of Advanced Clinical Medicine, Peking University, Beijing, China.

ORCID-Profile: Kezhong Chen, Mantang Qiu

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • Beijing Nova Program
  • Research Unit of Intelligence Diagnosis and Treatment in Early Non-small Cell Lung Cancer (Chinese Academy of Medical Sciences)
  • Peking University People's Hospital Research and Development Founds
  • Peking University Medicine Sailing Program for Young Scholars' Scientific & Technological Innovation
  • National Key Research and Development Program of China

Zitieren

APA

Li, H., Liu, Z., Chen, S., Cai, J., Wang, P., Chen, K., & Qiu, M. (2024). Restoring expression of tumour suppressor PTEN by engineered circular RNA‐enhanced Osimertinib sensitivity in non‐small cell lung cancer. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1792

Vancouver

Li H, Liu Z, Chen S, Cai J, Wang P, Chen K, et al. Restoring expression of tumour suppressor PTEN by engineered circular RNA‐enhanced Osimertinib sensitivity in non‐small cell lung cancer. Clinical and Translational Medicine. 2024. doi:10.1002/ctm2.1792

BibTeX
@article{Li2024,
  author = {Li, Haoran and Liu, Zheng and Chen, Shaoyi and Cai, Jingsheng and Wang, Peiyu and Chen, Kezhong and Qiu, Mantang},
  title = {Restoring expression of tumour suppressor PTEN by engineered circular RNA‐enhanced Osimertinib sensitivity in non‐small cell lung cancer},
  journal = {Clinical and Translational Medicine},
  year = {2024},
  doi = {10.1002/ctm2.1792}
}
Kostenlos starten →